ATE466579T1 - Verfahren zur herstellung von benzimidazolen - Google Patents
Verfahren zur herstellung von benzimidazolenInfo
- Publication number
- ATE466579T1 ATE466579T1 AT04820975T AT04820975T ATE466579T1 AT E466579 T1 ATE466579 T1 AT E466579T1 AT 04820975 T AT04820975 T AT 04820975T AT 04820975 T AT04820975 T AT 04820975T AT E466579 T1 ATE466579 T1 AT E466579T1
- Authority
- AT
- Austria
- Prior art keywords
- benzimidazoles
- producing
- salts
- reconstitutable
- discloses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1164MU2003 | 2003-11-05 | ||
PCT/IN2004/000342 WO2005065682A2 (en) | 2003-11-05 | 2004-11-03 | Rabeprazole containing formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE466579T1 true ATE466579T1 (de) | 2010-05-15 |
Family
ID=34746668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04820975T ATE466579T1 (de) | 2003-11-05 | 2004-11-03 | Verfahren zur herstellung von benzimidazolen |
Country Status (11)
Country | Link |
---|---|
US (1) | US20070014875A1 (de) |
EP (1) | EP1713476B1 (de) |
AT (1) | ATE466579T1 (de) |
BR (1) | BRPI0416027A (de) |
CY (1) | CY1110717T1 (de) |
DE (1) | DE602004027088D1 (de) |
DK (1) | DK1713476T3 (de) |
ES (1) | ES2344905T3 (de) |
PL (1) | PL1713476T3 (de) |
PT (1) | PT1713476E (de) |
WO (1) | WO2005065682A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ572007A (en) * | 2006-05-09 | 2010-12-24 | Astrazeneca Ab | Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation |
CN102138907A (zh) * | 2010-02-02 | 2011-08-03 | 南京长澳医药科技有限公司 | 一种稳定的雷贝拉唑钠冻干制剂及其制备方法 |
CN103463636B (zh) * | 2013-09-17 | 2015-05-27 | 天津市嵩锐医药科技有限公司 | 一种供注射用的泮托拉唑钠药物组合物 |
MA41623A (fr) * | 2015-11-26 | 2018-01-09 | Verano Ilac Sanayi Ve Ticaret A S | Composition lyophilisée de composé de benzimidazole |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0651727T3 (da) * | 1992-07-20 | 1997-10-13 | Unilever Plc | Fremstilling af gashydrater. |
HU226778B1 (en) | 1992-07-28 | 2009-10-28 | Astra Ab | Injection and injection kit containing omeprazole and its analogs |
TW280770B (de) * | 1993-10-15 | 1996-07-11 | Takeda Pharm Industry Co Ltd | |
US7396841B2 (en) * | 2000-08-18 | 2008-07-08 | Takeda Pharmaceutical Company Limited | Injections |
-
2004
- 2004-11-03 BR BRPI0416027-4A patent/BRPI0416027A/pt not_active IP Right Cessation
- 2004-11-03 PL PL04820975T patent/PL1713476T3/pl unknown
- 2004-11-03 WO PCT/IN2004/000342 patent/WO2005065682A2/en active Application Filing
- 2004-11-03 DK DK04820975.3T patent/DK1713476T3/da active
- 2004-11-03 ES ES04820975T patent/ES2344905T3/es active Active
- 2004-11-03 DE DE602004027088T patent/DE602004027088D1/de active Active
- 2004-11-03 US US10/574,666 patent/US20070014875A1/en not_active Abandoned
- 2004-11-03 EP EP04820975A patent/EP1713476B1/de not_active Revoked
- 2004-11-03 PT PT04820975T patent/PT1713476E/pt unknown
- 2004-11-03 AT AT04820975T patent/ATE466579T1/de active
-
2010
- 2010-07-27 CY CY20101100704T patent/CY1110717T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005065682A2 (en) | 2005-07-21 |
US20070014875A1 (en) | 2007-01-18 |
DK1713476T3 (da) | 2010-08-09 |
EP1713476A2 (de) | 2006-10-25 |
PT1713476E (pt) | 2010-08-04 |
WO2005065682A3 (en) | 2005-09-01 |
PL1713476T3 (pl) | 2010-10-29 |
EP1713476B1 (de) | 2010-05-05 |
BRPI0416027A (pt) | 2007-01-02 |
DE602004027088D1 (de) | 2010-06-17 |
ES2344905T3 (es) | 2010-09-09 |
CY1110717T1 (el) | 2015-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121125T1 (el) | Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης | |
CY1113177T1 (el) | Φαινυλαμινο-βενζοξαζολ-υποκατεστημενα καρβοξυλικα οξεα, μεθοδος για την παρασκευη τους και η χρηση τους ως φαρμακων | |
NO20071914L (no) | Kontrollert avleveringssystem | |
PE20141585A1 (es) | Composicion farmaceutica estabilizada a base de un compuesto no petidico | |
MX2009009754A (es) | Compuestos de 4-piperidinilurea como inhibidores de epoxido hidrolasa soluble. | |
ATE414077T1 (de) | Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivaten | |
DE602007005244D1 (de) | N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinon, verfahren zu dessen herstellung und pharmazeutische verwendung | |
ATE528301T1 (de) | Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen | |
PA8636101A1 (es) | Metodo para la preparacion de acidos hidroxamicos | |
DE602005016282D1 (de) | Verfahren zur herstellung von camptothecin-derivaten | |
DE60335279D1 (de) | Neues verfahren zur stabilisierung von diagnostischen und therapeutischen verbindungen in einem kationischen trägersystem | |
ATE399156T1 (de) | Neue indol- oder benzimidazol-derivate | |
CY1110717T1 (el) | Ενα πρωτοτυπο συστημα χορηγησης φαρμακου για τους αναστολεις αντλιας πρωτονιων και τις διαδικασιες τους | |
MA32588B1 (fr) | Derives azotes de la pancratistatine | |
ATE534643T1 (de) | Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers | |
RU2010141793A (ru) | Терапевтические замещенные циклопентаны | |
ATE339202T1 (de) | Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs | |
MX2010013695A (es) | Nuevos derivados de (piperazinilo puente)-1-alcanona y su uso como inhibidores de p75. | |
EA200501164A1 (ru) | Индазоламиды с аналгетической активностью | |
EA200800706A1 (ru) | Способ приготовления кандесартана цилексетила | |
EA200501565A1 (ru) | Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса | |
ATE443709T1 (de) | Verfahren zur herstellung von 9,10-dihydro-9-oxa- 10-organyl-oxyphosphaphenanthren-10-oxid oder - thion und an den phenylgruppen substituierten derivativen desselben | |
SE0301884D0 (sv) | New use III | |
UY30412A1 (es) | Derivados de las 1-([1h-benzimidazol-5il]carbonil)-piperidin-carboxamidas n-sustituidas, composiciones farmacéuticas conteniéndolos, proceso de preparacion y aplicaciones | |
DE602004023509D1 (de) | Pharmazeutische zusammensetzungen eines kurzwirkenden sedativen hypnosemittels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1713476 Country of ref document: EP |